{"transactions":[{"id":876524,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64218,"kind":"person","name":"Kelly Timothy P","position":1,"cik":"0001754067","reported_name":"Kelly Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:01:13.000Z","date":"2026-02-25","kind":"sale","planned":false,"acquired":false,"shares":6228,"price":1.93,"value":12020.04,"ownership":{"direct":true},"balance_after":73125,"source":{"system":"sec-edgar","filing":"0001754067-26-000004","document":"wk-form4_1772226070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000175406726000004/wk-form4_1772226070.xml","form_type":"4"}},{"id":883924,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64218,"kind":"person","name":"Kelly Timothy P","position":1,"cik":"0001754067","reported_name":"Kelly Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Option to purchase Common Stock","published_at":"2026-02-25T01:54:41.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":202500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to\nthe Issuer through each such vesting date."}],"balance_after":202500,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":202500},"source":{"system":"sec-edgar","filing":"0001754067-26-000002","document":"wk-form4_1771984478.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000175406726000002/wk-form4_1771984478.xml","form_type":"4"}},{"id":883923,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64218,"kind":"person","name":"Kelly Timothy P","position":1,"cik":"0001754067","reported_name":"Kelly Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-25T01:54:41.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":3147,"price":1.96,"value":6168.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the number of shares of common stock that were sold pursuant to the Issuer's mandatory sell-to-cover policy for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the number of shares of common stock that were sold pursuant to the Issuer's mandatory sell-to-cover policy for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person."}],"balance_after":79353,"source":{"system":"sec-edgar","filing":"0001754067-26-000002","document":"wk-form4_1771984478.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000175406726000002/wk-form4_1771984478.xml","form_type":"4"}},{"id":883922,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64218,"kind":"person","name":"Kelly Timothy P","position":1,"cik":"0001754067","reported_name":"Kelly Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-25T01:54:41.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be\nsettled in stock within 30 days after each vesting date."}],"balance_after":82500,"source":{"system":"sec-edgar","filing":"0001754067-26-000002","document":"wk-form4_1771984478.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000175406726000002/wk-form4_1771984478.xml","form_type":"4"}},{"id":883921,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64893,"kind":"person","name":"Khan Ruhi Ahmad","position":1,"cik":"0001891113","reported_name":"Khan Ruhi Ahmad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Option to purchase Common Stock","published_at":"2026-02-25T01:54:04.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":202500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to\nthe Issuer through each such vesting date."}],"balance_after":202500,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":202500},"source":{"system":"sec-edgar","filing":"0001891113-26-000002","document":"wk-form4_1771984441.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000189111326000002/wk-form4_1771984441.xml","form_type":"4"}},{"id":883920,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64893,"kind":"person","name":"Khan Ruhi Ahmad","position":1,"cik":"0001891113","reported_name":"Khan Ruhi Ahmad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-02-25T01:54:04.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":6938,"price":1.96,"value":13598.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the number of shares of common stock that were sold in a \"sell-to-cover\" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and\ndoes not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the number of shares of common stock that were sold in a \"sell-to-cover\" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and\ndoes not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs."}],"balance_after":104998,"source":{"system":"sec-edgar","filing":"0001891113-26-000002","document":"wk-form4_1771984441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000189111326000002/wk-form4_1771984441.xml","form_type":"4"}},{"id":883919,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64893,"kind":"person","name":"Khan Ruhi Ahmad","position":1,"cik":"0001891113","reported_name":"Khan Ruhi Ahmad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-02-25T01:54:04.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":111936,"source":{"system":"sec-edgar","filing":"0001891113-26-000002","document":"wk-form4_1771984441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000189111326000002/wk-form4_1771984441.xml","form_type":"4"}},{"id":884396,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase Common Stock","published_at":"2026-02-24T20:54:36.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":202500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to\nthe Issuer through each such vesting date."}],"balance_after":202500,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":202500},"source":{"system":"sec-edgar","filing":"0001231321-26-000002","document":"wk-form4_1771984473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000123132126000002/wk-form4_1771984473.xml","form_type":"4"}},{"id":884395,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-24T20:54:36.000Z","date":"2026-02-24","kind":"sale","planned":false,"acquired":false,"shares":6938,"price":1.96,"value":13598.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the number of shares of common stock that were sold in a \"sell-to-cover\" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the number of shares of common stock that were sold in a \"sell-to-cover\" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs."}],"balance_after":481564,"source":{"system":"sec-edgar","filing":"0001231321-26-000002","document":"wk-form4_1771984473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000123132126000002/wk-form4_1771984473.xml","form_type":"4"}},{"id":884394,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-02-24T20:54:36.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":488502,"source":{"system":"sec-edgar","filing":"0001231321-26-000002","document":"wk-form4_1771984473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000123132126000002/wk-form4_1771984473.xml","form_type":"4"}},{"id":886282,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65051,"kind":"person","name":"Albertson Tina M.","position":1,"cik":"0001917391","reported_name":"Albertson Tina M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase Common Stock","published_at":"2026-02-24T20:53:47.000Z","date":"2026-02-20","kind":"grant","planned":true,"acquired":true,"shares":247500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to\nthe Issuer through each such vesting date."}],"balance_after":247500,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":247500},"source":{"system":"sec-edgar","filing":"0001917391-26-000002","document":"wk-form4_1771984424.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1917391/000191739126000002/wk-form4_1771984424.xml","form_type":"4"}},{"id":886281,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65051,"kind":"person","name":"Albertson Tina M.","position":1,"cik":"0001917391","reported_name":"Albertson Tina M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-24T20:53:47.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":1066,"price":1.96,"value":2089.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the number of shares of common stock that were sold in a \"sell-to-cover\" transaction for the sole purpose of\nsatisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and\ndoes not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading\nplan in the form of a durable sell-to-cover instruction adopted by the reporting person on August 12,  2024. The trading plan\nprovides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding\nobligations incurred in connection with the vesting of RSUs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the number of shares of common stock that were sold in a \"sell-to-cover\" transaction for the sole purpose of\nsatisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and\ndoes not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading\nplan in the form of a durable sell-to-cover instruction adopted by the reporting person on August 12,  2024. The trading plan\nprovides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding\nobligations incurred in connection with the vesting of RSUs."}],"balance_after":68523,"source":{"system":"sec-edgar","filing":"0001917391-26-000002","document":"wk-form4_1771984424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1917391/000191739126000002/wk-form4_1771984424.xml","form_type":"4"}},{"id":886280,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65051,"kind":"person","name":"Albertson Tina M.","position":1,"cik":"0001917391","reported_name":"Albertson Tina M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-24T20:53:47.000Z","date":"2026-02-20","kind":"grant","planned":true,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be\nsettled in stock within 30 days after each vesting date."}],"balance_after":69589,"source":{"system":"sec-edgar","filing":"0001917391-26-000002","document":"wk-form4_1771984424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1917391/000191739126000002/wk-form4_1771984424.xml","form_type":"4"}},{"id":890214,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T22:28:13.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001880609-26-000002","document":"wk-form4_1771626490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000188060926000002/wk-form4_1771626490.xml","form_type":"4"}},{"id":890213,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65378,"kind":"person","name":"Richardson-Heron Dara","position":1,"cik":"0001893193","reported_name":"Richardson-Heron Dara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T22:27:53.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001893193-26-000003","document":"wk-form4_1771626471.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000189319326000003/wk-form4_1771626471.xml","form_type":"4"}},{"id":890212,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64675,"kind":"person","name":"JOHNSON DAVID LEE","position":1,"cik":"0001733883","reported_name":"JOHNSON DAVID LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T22:27:42.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001733883-26-000004","document":"wk-form4_1771626459.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000173388326000004/wk-form4_1771626459.xml","form_type":"4"}},{"id":890395,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T22:27:35.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001230724-26-000004","document":"wk-form4_1771626452.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230724/000123072426000004/wk-form4_1771626452.xml","form_type":"4"}},{"id":890662,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":40595,"kind":"person","name":"Braunstein Scott","position":1,"cik":"0001643875","reported_name":"Braunstein Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T22:27:05.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001643875-26-000004","document":"wk-form4_1771626422.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643875/000164387526000004/wk-form4_1771626422.xml","form_type":"4"}},{"id":890208,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T22:26:37.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":247500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of the total number of shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2030, subject to the reporting person continuing to provide service to\nthe Issuer through each such vesting date."}],"balance_after":247500,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":247500},"source":{"system":"sec-edgar","filing":"0001762893-26-000002","document":"wk-form4_1771626395.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000176289326000002/wk-form4_1771626395.xml","form_type":"4"}},{"id":890207,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-20T22:26:37.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":72360,"source":{"system":"sec-edgar","filing":"0001762893-26-000002","document":"wk-form4_1771626395.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000176289326000002/wk-form4_1771626395.xml","form_type":"4"}},{"id":890922,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65438,"kind":"person","name":"Zheng Ran","position":1,"cik":"0001885914","reported_name":"Zheng Ran","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T17:28:17.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001885914-26-000002","document":"wk-form4_1771626495.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885914/000188591426000002/wk-form4_1771626495.xml","form_type":"4"}},{"id":891839,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T17:28:08.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001683811-26-000002","document":"wk-form4_1771626484.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000168381126000002/wk-form4_1771626484.xml","form_type":"4"}},{"id":890694,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2026-02-20T17:26:26.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":682500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the total number of shares subject to this option\nwill vest on each monthly anniversary of the grant date such that the option will\nbe fully vested on February 20, 2030, subject to the reporting person continuing to\nprovide service to the Issuer through each such vesting date."}],"balance_after":682500,"derivative":{"exercise_price":1.8,"expiration_date":"2036-02-19","underlying":"Common Stock","underlying_shares":682500},"source":{"system":"sec-edgar","filing":"0001670579-26-000002","document":"wk-form4_1771626383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000167057926000002/wk-form4_1771626383.xml","form_type":"4"}},{"id":890693,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-20T17:26:26.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":151700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2027, subject to the reporting person continuing to provide service to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":447150,"source":{"system":"sec-edgar","filing":"0001670579-26-000002","document":"wk-form4_1771626383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000167057926000002/wk-form4_1771626383.xml","form_type":"4"}},{"id":1203742,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-17T08:01:22.000Z","date":"2025-03-14","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.02,"value":20400.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades on 3/14/2025 at prices ranging from $1.00 to $1.03 per share, inclusive. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the specified range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares are held by The City Canyon Family Trust dated May 31, 2021, of which the Reporting Person is a Co-Trustee with her spouse."}],"balance_after":3369395,"source":{"system":"sec-edgar","filing":"0001670579-25-000008","document":"wk-form4_1742212876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000167057925000008/wk-form4_1742212876.xml","form_type":"4"}},{"id":1252249,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64893,"kind":"person","name":"Khan Ruhi Ahmad","position":1,"cik":"0001891113","reported_name":"Khan Ruhi Ahmad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Option to purchase Common Stock","published_at":"2025-02-22T01:19:26.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to\nthe Issuer through the applicable vesting dates."}],"balance_after":170000,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001891113-25-000003","document":"wk-form4_1740187160.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000189111325000003/wk-form4_1740187160.xml","form_type":"4"}},{"id":1252248,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64893,"kind":"person","name":"Khan Ruhi Ahmad","position":1,"cik":"0001891113","reported_name":"Khan Ruhi Ahmad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-02-22T01:19:26.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":3564,"price":1.35,"value":4811.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the number of shares of common stock that were sold in a \"sell to cover\" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the number of shares of common stock that were sold in a \"sell to cover\" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades on 2/21/2025 at prices ranging from $1.32 to $1.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the specified range."}],"balance_after":66936,"source":{"system":"sec-edgar","filing":"0001891113-25-000003","document":"wk-form4_1740187160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000189111325000003/wk-form4_1740187160.xml","form_type":"4"}},{"id":1252247,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64893,"kind":"person","name":"Khan Ruhi Ahmad","position":1,"cik":"0001891113","reported_name":"Khan Ruhi Ahmad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-02-22T01:19:26.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":70500,"source":{"system":"sec-edgar","filing":"0001891113-25-000003","document":"wk-form4_1740187160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000189111325000003/wk-form4_1740187160.xml","form_type":"4"}},{"id":1252251,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64218,"kind":"person","name":"Kelly Timothy P","position":1,"cik":"0001754067","reported_name":"Kelly Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Option to purchase Common Stock","published_at":"2025-02-22T01:18:50.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to\nthe Issuer through the applicable vesting dates."}],"balance_after":170000,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001754067-25-000003","document":"wk-form4_1740187125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000175406725000003/wk-form4_1740187125.xml","form_type":"4"}},{"id":1252250,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64218,"kind":"person","name":"Kelly Timothy P","position":1,"cik":"0001754067","reported_name":"Kelly Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-02-22T01:18:50.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001754067-25-000003","document":"wk-form4_1740187125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000175406725000003/wk-form4_1740187125.xml","form_type":"4"}},{"id":1252246,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":82903,"kind":"person","name":"Kanner Steven","position":1,"cik":"0001871131","reported_name":"Kanner Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Common Stock","published_at":"2025-02-22T01:18:15.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":170000,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001871131-25-000003","document":"wk-form4_1740187088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000187113125000003/wk-form4_1740187088.xml","form_type":"4"}},{"id":1252245,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":82903,"kind":"person","name":"Kanner Steven","position":1,"cik":"0001871131","reported_name":"Kanner Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-22T01:18:15.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":3564,"price":1.35,"value":4811.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Reflects the number of shares of common stock that were sold in a \"sell to cover\" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting\nperson and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs."},{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects the number of shares of common stock that were sold in a \"sell to cover\" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting\nperson and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades on 2/21/2025 at prices ranging from $1.32 to $1.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the specified range."}],"balance_after":431556,"source":{"system":"sec-edgar","filing":"0001871131-25-000003","document":"wk-form4_1740187088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000187113125000003/wk-form4_1740187088.xml","form_type":"4"}},{"id":1252244,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":82903,"kind":"person","name":"Kanner Steven","position":1,"cik":"0001871131","reported_name":"Kanner Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-22T01:18:15.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,583 shares purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan on February 15, 2025."}],"balance_after":435120,"source":{"system":"sec-edgar","filing":"0001871131-25-000003","document":"wk-form4_1740187088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000187113125000003/wk-form4_1740187088.xml","form_type":"4"}},{"id":1252243,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-02-22T01:17:04.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer\nthrough each such vesting date."}],"balance_after":40500,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001880609-25-000003","document":"wk-form4_1740187018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000188060925000003/wk-form4_1740187018.xml","form_type":"4"}},{"id":1252242,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65378,"kind":"person","name":"Richardson-Heron Dara","position":1,"cik":"0001893193","reported_name":"Richardson-Heron Dara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-02-22T01:15:40.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer\nthrough each such vesting date."}],"balance_after":40500,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001893193-25-000004","document":"wk-form4_1740186934.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000189319325000004/wk-form4_1740186934.xml","form_type":"4"}},{"id":1252241,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64675,"kind":"person","name":"JOHNSON DAVID LEE","position":1,"cik":"0001733883","reported_name":"JOHNSON DAVID LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-02-22T01:14:38.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer\nthrough each such vesting date."}],"balance_after":40500,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001733883-25-000003","document":"wk-form4_1740186872.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000173388325000003/wk-form4_1740186872.xml","form_type":"4"}},{"id":1252482,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-02-22T01:14:05.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer\nthrough each such vesting date."}],"balance_after":40500,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001230724-25-000003","document":"wk-form4_1740186837.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230724/000123072425000003/wk-form4_1740186837.xml","form_type":"4"}},{"id":1252920,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":40595,"kind":"person","name":"Braunstein Scott","position":1,"cik":"0001643875","reported_name":"Braunstein Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-02-22T01:13:27.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":40500,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001643875-25-000003","document":"wk-form4_1740186801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643875/000164387525000003/wk-form4_1740186801.xml","form_type":"4"}},{"id":1252955,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2025-02-21T20:21:07.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":618250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to\nthe Issuer through the applicable vesting dates."}],"balance_after":618250,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":618250},"source":{"system":"sec-edgar","filing":"0001670579-25-000003","document":"wk-form4_1740187261.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000167057925000003/wk-form4_1740187261.xml","form_type":"4"}},{"id":1252954,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-21T20:21:07.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":136750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be\nsettled in stock within 30 days after each vesting date."}],"balance_after":295450,"source":{"system":"sec-edgar","filing":"0001670579-25-000003","document":"wk-form4_1740187261.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000167057925000003/wk-form4_1740187261.xml","form_type":"4"}},{"id":1254122,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65051,"kind":"person","name":"Albertson Tina M.","position":1,"cik":"0001917391","reported_name":"Albertson Tina M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase Common Stock","published_at":"2025-02-21T20:20:34.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":66137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to\nthe Issuer through the applicable vesting dates."}],"balance_after":66137,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":66137},"source":{"system":"sec-edgar","filing":"0001917391-25-000003","document":"wk-form4_1740187228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1917391/000191739125000003/wk-form4_1740187228.xml","form_type":"4"}},{"id":1254121,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65051,"kind":"person","name":"Albertson Tina M.","position":1,"cik":"0001917391","reported_name":"Albertson Tina M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-21T20:20:34.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":14589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be\nsettled in stock within 30 days after each vesting date."}],"balance_after":14589,"source":{"system":"sec-edgar","filing":"0001917391-25-000003","document":"wk-form4_1740187228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1917391/000191739125000003/wk-form4_1740187228.xml","form_type":"4"}},{"id":1252501,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase Common Stock","published_at":"2025-02-21T20:19:55.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2026, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to\nthe Issuer through the applicable vesting dates."}],"balance_after":170000,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001231321-25-000003","document":"wk-form4_1740187189.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000123132125000003/wk-form4_1740187189.xml","form_type":"4"}},{"id":1252500,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-21T20:19:55.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":3564,"price":1.35,"value":4811.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the number of shares of common stock that were sold in a \"sell to cover\" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the number of shares of common stock that were sold in a \"sell to cover\" transaction for the sole purpose of satisfying tax withholding obligations in connection with the vesting of RSUs previously granted to the reporting person and does not represent a discretionary trade by the reporting person. This transaction was made pursuant to a Rule 10b5-1 trading plan in the form of a durable sell-to-cover instruction adopted prior to the 2023 amendments to Rule 10b5-1. The trading plan provides for the automatic sale of shares of common stock necessary to satisfy the reporting person's tax withholding obligations incurred in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades on 2/21/2025 at prices ranging from $1.32 to $1.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the specified range."}],"balance_after":443502,"source":{"system":"sec-edgar","filing":"0001231321-25-000003","document":"wk-form4_1740187189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000123132125000003/wk-form4_1740187189.xml","form_type":"4"}},{"id":1252499,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-21T20:19:55.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2026, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be\nsettled in stock within 30 days after each vesting date."}],"balance_after":447066,"source":{"system":"sec-edgar","filing":"0001231321-25-000003","document":"wk-form4_1740187189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000123132125000003/wk-form4_1740187189.xml","form_type":"4"}},{"id":1253312,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65438,"kind":"person","name":"Zheng Ran","position":1,"cik":"0001885914","reported_name":"Zheng Ran","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-02-21T20:17:40.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer\nthrough each such vesting date."}],"balance_after":40500,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001885914-25-000003","document":"wk-form4_1740187054.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885914/000188591425000003/wk-form4_1740187054.xml","form_type":"4"}},{"id":1254302,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-02-21T20:16:25.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":40500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2026, subject to the reporting person continuing to provide service to the Issuer\nthrough each such vesting date."}],"balance_after":40500,"derivative":{"exercise_price":1.41,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":40500},"source":{"system":"sec-edgar","filing":"0001683811-25-000003","document":"wk-form4_1740186979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000168381125000003/wk-form4_1740186979.xml","form_type":"4"}},{"id":1290541,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-30T21:02:12.000Z","date":"2025-01-29","kind":"purchase","planned":false,"acquired":true,"shares":17360,"price":1.42,"value":24651.2,"ownership":{"direct":true},"balance_after":17360,"source":{"system":"sec-edgar","filing":"0001762893-25-000009","document":"wk-form4_1738270924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000176289325000009/wk-form4_1738270924.xml","form_type":"4"}},{"id":1304875,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65377,"kind":"person","name":"Ryali Sriram","position":1,"cik":"0001762893","reported_name":"Ryali Sriram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase Common Stock","published_at":"2025-01-10T22:06:04.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2026, and the remaining shares subject to the option shall vest monthly thereafter (1/48 of the shares per month for the 36 months following January 2, 2026), subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":300000,"derivative":{"exercise_price":1.64,"expiration_date":"2035-01-09","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001762893-25-000006","document":"wk-form4_1736546757.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000176289325000006/wk-form4_1736546757.xml","form_type":"4"}},{"id":1353792,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2024-11-22T21:01:32.000Z","date":"2024-11-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that will vest in full on November 20, 2025, subject to the reporting person's continued services to the Issuer through the vesting date. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":118854,"source":{"system":"sec-edgar","filing":"0001871155-24-000005","document":"wk-form4_1732309285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000187115524000005/wk-form4_1732309285.xml","form_type":"4"}},{"id":1428264,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65051,"kind":"person","name":"Albertson Tina M.","position":1,"cik":"0001917391","reported_name":"Albertson Tina M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase Common Stock","published_at":"2024-08-20T16:07:04.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options will vest upon the one-year anniversary of the grant date, August 19, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":300000,"derivative":{"exercise_price":2.18,"expiration_date":"2034-08-18","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001917391-24-000009","document":"wk-form4_1724184417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1917391/000191739124000009/wk-form4_1724184417.xml","form_type":"4"}},{"id":1624592,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T22:28:33.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":153000,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":153000},"source":{"system":"sec-edgar","filing":"0001628280-24-006433","document":"wk-form4_1708640897.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000162828024006433/wk-form4_1708640897.xml","form_type":"4"}},{"id":1624591,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T22:28:33.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,888 shares purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan on February 15, 2022 for $9.85 per share."}],"balance_after":59224,"source":{"system":"sec-edgar","filing":"0001628280-24-006433","document":"wk-form4_1708640897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000162828024006433/wk-form4_1708640897.xml","form_type":"4"}},{"id":1624590,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64893,"kind":"person","name":"Khan Ruhi Ahmad","position":1,"cik":"0001891113","reported_name":"Khan Ruhi Ahmad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T22:21:46.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":153000,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":153000},"source":{"system":"sec-edgar","filing":"0001628280-24-006425","document":"wk-form4_1708640476.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000162828024006425/wk-form4_1708640476.xml","form_type":"4"}},{"id":1624589,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64893,"kind":"person","name":"Khan Ruhi Ahmad","position":1,"cik":"0001891113","reported_name":"Khan Ruhi Ahmad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-02-22T22:21:46.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001628280-24-006425","document":"wk-form4_1708640476.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000162828024006425/wk-form4_1708640476.xml","form_type":"4"}},{"id":1624588,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":82903,"kind":"person","name":"Kanner Steven","position":1,"cik":"0001871131","reported_name":"Kanner Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T22:15:05.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":153000,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":153000},"source":{"system":"sec-edgar","filing":"0001628280-24-006419","document":"wk-form4_1708640094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000162828024006419/wk-form4_1708640094.xml","form_type":"4"}},{"id":1624587,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":82903,"kind":"person","name":"Kanner Steven","position":1,"cik":"0001871131","reported_name":"Kanner Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-22T22:15:05.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":387037,"source":{"system":"sec-edgar","filing":"0001628280-24-006419","document":"wk-form4_1708640094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000162828024006419/wk-form4_1708640094.xml","form_type":"4"}},{"id":1624586,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T22:10:50.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2025, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":39500,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":39500},"source":{"system":"sec-edgar","filing":"0001628280-24-006414","document":"wk-form4_1708639829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000162828024006414/wk-form4_1708639829.xml","form_type":"4"}},{"id":1624585,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65378,"kind":"person","name":"Richardson-Heron Dara","position":1,"cik":"0001893193","reported_name":"Richardson-Heron Dara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T22:06:12.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2025, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":39500,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":39500},"source":{"system":"sec-edgar","filing":"0001628280-24-006411","document":"wk-form4_1708639530.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000162828024006411/wk-form4_1708639530.xml","form_type":"4"}},{"id":1624584,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64675,"kind":"person","name":"JOHNSON DAVID LEE","position":1,"cik":"0001733883","reported_name":"JOHNSON DAVID LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T22:01:35.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2025, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":39500,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":39500},"source":{"system":"sec-edgar","filing":"0001628280-24-006407","document":"wk-form4_1708639272.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000162828024006407/wk-form4_1708639272.xml","form_type":"4"}},{"id":1624995,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T21:57:17.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2025, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":39500,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":39500},"source":{"system":"sec-edgar","filing":"0001628280-24-006405","document":"wk-form4_1708639013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230724/000162828024006405/wk-form4_1708639013.xml","form_type":"4"}},{"id":1625354,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":40595,"kind":"person","name":"Braunstein Scott","position":1,"cik":"0001643875","reported_name":"Braunstein Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T21:54:24.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2025, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":39500,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":39500},"source":{"system":"sec-edgar","filing":"0001628280-24-006402","document":"wk-form4_1708638851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643875/000162828024006402/wk-form4_1708638851.xml","form_type":"4"}},{"id":1625024,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T17:24:10.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":153000,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":153000},"source":{"system":"sec-edgar","filing":"0001628280-24-006429","document":"wk-form4_1708640636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000162828024006429/wk-form4_1708640636.xml","form_type":"4"}},{"id":1625023,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-22T17:24:10.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":409566,"source":{"system":"sec-edgar","filing":"0001628280-24-006429","document":"wk-form4_1708640636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000162828024006429/wk-form4_1708640636.xml","form_type":"4"}},{"id":1625413,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T17:18:24.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":546950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":546950,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":546950},"source":{"system":"sec-edgar","filing":"0001628280-24-006421","document":"wk-form4_1708640281.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000162828024006421/wk-form4_1708640281.xml","form_type":"4"}},{"id":1625412,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-22T17:18:24.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":118700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."}],"balance_after":158700,"source":{"system":"sec-edgar","filing":"0001628280-24-006421","document":"wk-form4_1708640281.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000162828024006421/wk-form4_1708640281.xml","form_type":"4"}},{"id":1625707,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65438,"kind":"person","name":"Zheng Ran","position":1,"cik":"0001885914","reported_name":"Zheng Ran","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T17:12:50.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2025, subject to the reporting person continuing to provide service to the Issuer through each such vesting\ndate."}],"balance_after":39500,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":39500},"source":{"system":"sec-edgar","filing":"0001628280-24-006416","document":"wk-form4_1708639949.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885914/000162828024006416/wk-form4_1708639949.xml","form_type":"4"}},{"id":1627045,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T17:08:41.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":39500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 20, 2025, subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":39500,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":39500},"source":{"system":"sec-edgar","filing":"0001628280-24-006412","document":"wk-form4_1708639705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000162828024006412/wk-form4_1708639705.xml","form_type":"4"}},{"id":1652995,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":82903,"kind":"person","name":"Kanner Steven","position":1,"cik":"0001871131","reported_name":"Kanner Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Common Stock","published_at":"2024-02-08T22:06:48.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":30577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to this option vested on October 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates."}],"balance_after":21623,"derivative":{"exercise_price":2.69,"expiration_date":"2029-09-30","underlying":"Common Stock","underlying_shares":30577},"source":{"system":"sec-edgar","filing":"0001871131-24-000002","document":"wk-form4_1707429995.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000187113124000002/wk-form4_1707429995.xml","form_type":"4"}},{"id":1652994,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":82903,"kind":"person","name":"Kanner Steven","position":1,"cik":"0001871131","reported_name":"Kanner Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-08T22:06:48.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":30577,"price":2.69,"value":82252.13,"ownership":{"direct":true},"balance_after":354037,"source":{"system":"sec-edgar","filing":"0001871131-24-000002","document":"wk-form4_1707429995.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000187113124000002/wk-form4_1707429995.xml","form_type":"4"}},{"id":1682289,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64218,"kind":"person","name":"Kelly Timothy P","position":1,"cik":"0001754067","reported_name":"Kelly Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Option to purchase Common Stock","published_at":"2024-01-09T21:10:25.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 1,  2025, and the remaining shares subject to the option shall vest monthly thereafter (1/48 of the shares per month for the 36 months following the one-year cliff), subject to the Reporting Person's continued\nservice to the Issuer through the applicable vesting dates."}],"balance_after":300000,"derivative":{"exercise_price":5.74,"expiration_date":"2034-01-07","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001754067-24-000006","document":"wk-form4_1704834615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000175406724000006/wk-form4_1704834615.xml","form_type":"4"}},{"id":1860518,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2023-06-09T16:31:57.000Z","date":"2023-06-08","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to this option vested on June 12, 2019 and an additional 1/48th of the aggregate number of shares subject to the option vested on the corresponding day of each month thereafter until the option became fully vested on June 12, 2022."}],"balance_after":96350,"derivative":{"exercise_price":2.96,"expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001619856-23-000073","document":"wk-form4_1686342698.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000161985623000073/wk-form4_1686342698.xml","form_type":"4"}},{"id":1860517,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-09T16:31:57.000Z","date":"2023-06-08","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":2.96,"value":29600.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001619856-23-000073","document":"wk-form4_1686342698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000161985623000073/wk-form4_1686342698.xml","form_type":"4"}},{"id":1941706,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2023-03-22T16:16:22.000Z","date":"2023-03-20","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to this option vested on June 12, 2019 and an additional 1/48th of the aggregate number of shares subject to the option vested on the corresponding day of each month thereafter until the option became fully vested on June 12, 2022."}],"balance_after":106350,"derivative":{"exercise_price":2.96,"expiration_date":"2023-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001619856-23-000039","document":"wf-form4_167951616420908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000161985623000039/wf-form4_167951616420908.xml","form_type":"4"}},{"id":1941705,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-22T16:16:22.000Z","date":"2023-03-20","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":2.96,"value":29600.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001619856-23-000039","document":"wf-form4_167951616420908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000161985623000039/wf-form4_167951616420908.xml","form_type":"4"}},{"id":1995278,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":82903,"kind":"person","name":"Kanner Steven","position":1,"cik":"0001871131","reported_name":"Kanner Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T22:13:46.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":131000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on February 21, 2027, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":131000,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":131000},"source":{"system":"sec-edgar","filing":"0001619856-23-000027","document":"wf-form4_167719039206421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985623000027/wf-form4_167719039206421.xml","form_type":"4"}},{"id":1995276,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65378,"kind":"person","name":"Richardson-Heron Dara","position":1,"cik":"0001893193","reported_name":"Richardson-Heron Dara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T22:12:59.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 21, 2024,  subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":21500,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001619856-23-000026","document":"wf-form4_167719034786758.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985623000026/wf-form4_167719034786758.xml","form_type":"4"}},{"id":1995277,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64893,"kind":"person","name":"Khan Ruhi Ahmad","position":1,"cik":"0001891113","reported_name":"Khan Ruhi Ahmad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T22:12:25.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":131000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on February 21, 2027, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":131000,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":131000},"source":{"system":"sec-edgar","filing":"0001619856-23-000025","document":"wf-form4_167719032608820.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985623000025/wf-form4_167719032608820.xml","form_type":"4"}},{"id":1995922,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":40595,"kind":"person","name":"Braunstein Scott","position":1,"cik":"0001643875","reported_name":"Braunstein Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T22:11:32.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 21, 2024,  subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":21500,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001619856-23-000023","document":"wf-form4_167719023966401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643875/000161985623000023/wf-form4_167719023966401.xml","form_type":"4"}},{"id":1995562,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":1167,"kind":"person","name":"GUGGENHIME ANDREW","position":1,"cik":"0001230724","reported_name":"GUGGENHIME ANDREW","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T22:10:32.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 21, 2024,  subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":21500,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001619856-23-000022","document":"wf-form4_167719020813142.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230724/000161985623000022/wf-form4_167719020813142.xml","form_type":"4"}},{"id":1995275,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":66474,"kind":"person","name":"Rizvi Syed Ali-aamir","position":1,"cik":"0001897621","reported_name":"Rizvi Syed Ali-aamir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T22:09:37.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":131000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on February 21, 2027, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":131000,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":131000},"source":{"system":"sec-edgar","filing":"0001619856-23-000020","document":"wf-form4_167719014984142.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985623000020/wf-form4_167719014984142.xml","form_type":"4"}},{"id":1995274,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":38012,"kind":"person","name":"Whiting Nancy","position":1,"cik":"0001880609","reported_name":"Whiting Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T21:48:11.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 21, 2024,  subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":21500,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001619856-23-000018","document":"wf-form4_167718885507722.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985623000018/wf-form4_167718885507722.xml","form_type":"4"}},{"id":1995273,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T21:47:32.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":131000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on February 21, 2027, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":131000,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":131000},"source":{"system":"sec-edgar","filing":"0001619856-23-000017","document":"wf-form4_167718882178453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985623000017/wf-form4_167718882178453.xml","form_type":"4"}},{"id":1995272,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64675,"kind":"person","name":"JOHNSON DAVID LEE","position":1,"cik":"0001733883","reported_name":"JOHNSON DAVID LEE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T21:46:57.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 21, 2024,  subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":21500,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001619856-23-000016","document":"wf-form4_167718878109697.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985623000016/wf-form4_167718878109697.xml","form_type":"4"}},{"id":1995969,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65418,"kind":"person","name":"Haurwitz Rachel E.","position":1,"cik":"0001670579","reported_name":"Haurwitz Rachel E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T17:14:23.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":510500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on February 21, 2027, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":510500,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":510500},"source":{"system":"sec-edgar","filing":"0001619856-23-000028","document":"wf-form4_167719043346430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1670579/000161985623000028/wf-form4_167719043346430.xml","form_type":"4"}},{"id":1997514,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65549,"kind":"person","name":"Sacks Natalie","position":1,"cik":"0001683811","reported_name":"Sacks Natalie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T17:12:03.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 21, 2024,  subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":21500,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001619856-23-000024","document":"wf-form4_167719030244436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683811/000161985623000024/wf-form4_167719030244436.xml","form_type":"4"}},{"id":1995588,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T17:10:03.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":131000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on February 21, 2027, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":131000,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":131000},"source":{"system":"sec-edgar","filing":"0001619856-23-000021","document":"wf-form4_167719018333486.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000161985623000021/wf-form4_167719018333486.xml","form_type":"4"}},{"id":1996285,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":65438,"kind":"person","name":"Zheng Ran","position":1,"cik":"0001885914","reported_name":"Zheng Ran","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T17:09:04.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 21, 2024,  subject to the reporting person continuing to provide service to the Issuer through each such vesting date."}],"balance_after":21500,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001619856-23-000019","document":"wf-form4_167719010634615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885914/000161985623000019/wf-form4_167719010634615.xml","form_type":"4"}},{"id":2049386,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":66474,"kind":"person","name":"Rizvi Syed Ali-aamir","position":1,"cik":"0001897621","reported_name":"Rizvi Syed Ali-aamir","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-01-20T21:13:22.000Z","date":"2023-01-19","kind":"sale","acquired":false,"shares":5627,"price":6.31,"value":35506.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units as provided in standing \"sell to cover\" instructions."}],"balance_after":59373,"source":{"system":"sec-edgar","filing":"0001619856-23-000002","document":"wf-form4_167424918505378.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985623000002/wf-form4_167424918505378.xml","form_type":"4"}},{"id":2097750,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":82903,"kind":"person","name":"Kanner Steven","position":1,"cik":"0001871131","reported_name":"Kanner Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Option to purchase Common Stock","published_at":"2022-12-03T00:01:25.000Z","date":"2022-12-02","kind":"exercise","acquired":false,"shares":21401,"price":2.69,"value":57568.69,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to this option vested on October 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter, subject to the reporting person's continued services to the Issuer through the applicable vesting dates."}],"balance_after":52200,"derivative":{"exercise_price":2.69,"expiration_date":"2029-09-30","underlying":"Common Stock","underlying_shares":21401},"source":{"system":"sec-edgar","filing":"0001619856-22-000031","document":"wf-form4_167002566431978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985622000031/wf-form4_167002566431978.xml","form_type":"4"}},{"id":2097749,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":82903,"kind":"person","name":"Kanner Steven","position":1,"cik":"0001871131","reported_name":"Kanner Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-12-03T00:01:25.000Z","date":"2022-12-02","kind":"exercise","acquired":true,"shares":21401,"price":2.69,"value":57568.69,"ownership":{"direct":true},"balance_after":323460,"source":{"system":"sec-edgar","filing":"0001619856-22-000031","document":"wf-form4_167002566431978.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985622000031/wf-form4_167002566431978.xml","form_type":"4"}},{"id":2140064,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2022-10-07T21:13:51.000Z","date":"2022-10-06","kind":"exercise","acquired":false,"shares":2839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to this option vested on January 1, 2022 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on January 1, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":15337,"derivative":{"exercise_price":4.11,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":2839},"source":{"system":"sec-edgar","filing":"0001619856-22-000003","document":"wf-form4_166517721515147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985622000003/wf-form4_166517721515147.xml","form_type":"4"}},{"id":2140063,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Option to purchase Common Stock","published_at":"2022-10-07T21:13:51.000Z","date":"2022-10-06","kind":"exercise","acquired":false,"shares":2839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the shares subject to this option vested on January 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on January 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":1704,"derivative":{"exercise_price":2.69,"expiration_date":"2029-03-18","underlying":"Common Stock","underlying_shares":2839},"source":{"system":"sec-edgar","filing":"0001619856-22-000003","document":"wf-form4_166517721515147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985622000003/wf-form4_166517721515147.xml","form_type":"4"}},{"id":2140062,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-10-07T21:13:51.000Z","date":"2022-10-06","kind":"exercise","acquired":true,"shares":2839,"price":4.11,"value":11668.29,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,848 shares represented by restricted stock units (\"RSUs\") that vest in two equal annual installments beginning on August 22, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":116044,"source":{"system":"sec-edgar","filing":"0001619856-22-000003","document":"wf-form4_166517721515147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985622000003/wf-form4_166517721515147.xml","form_type":"4"}},{"id":2140061,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-10-07T21:13:51.000Z","date":"2022-10-06","kind":"exercise","acquired":true,"shares":2839,"price":2.69,"value":7636.91,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,848 shares represented by restricted stock units (\"RSUs\") that vest in two equal annual installments beginning on August 22, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":113205,"source":{"system":"sec-edgar","filing":"0001619856-22-000003","document":"wf-form4_166517721515147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985622000003/wf-form4_166517721515147.xml","form_type":"4"}},{"id":2140060,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":85723,"kind":"person","name":"Fischesser Ryan","position":1,"cik":"0001871155","reported_name":"Fischesser Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Controller"}}],"security":"Common Stock","published_at":"2022-10-07T21:13:51.000Z","date":"2022-10-06","kind":"sale","acquired":false,"shares":10000,"price":10.7958,"value":107958.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.67 to $10.94, inclusive. The reporting person undertakes to provide to Caribou Biosciences, Inc., any security holder of Caribou Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,848 shares represented by restricted stock units (\"RSUs\") that vest in two equal annual installments beginning on August 22, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":110366,"source":{"system":"sec-edgar","filing":"0001619856-22-000003","document":"wf-form4_166517721515147.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985622000003/wf-form4_166517721515147.xml","form_type":"4"}},{"id":2157169,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase Common Stock","published_at":"2022-09-16T16:14:35.000Z","date":"2022-09-15","kind":"exercise","acquired":false,"shares":27518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on October 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":47318,"derivative":{"exercise_price":2.69,"expiration_date":"2029-09-30","underlying":"Common Stock","underlying_shares":27518},"source":{"system":"sec-edgar","filing":"0001209191-22-050315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000120919122050315/doc4.xml","form_type":"4"}},{"id":2157168,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Option to purchase Common Stock","published_at":"2022-09-16T16:14:35.000Z","date":"2022-09-15","kind":"exercise","acquired":false,"shares":77,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vested in equal monthly installments until the option became fully vested on June 12, 2022."}],"balance_after":0,"derivative":{"exercise_price":2.69,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":77},"source":{"system":"sec-edgar","filing":"0001209191-22-050315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000120919122050315/doc4.xml","form_type":"4"}},{"id":2157167,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-09-16T16:14:35.000Z","date":"2022-09-15","kind":"exercise","acquired":true,"shares":27518,"price":2.69,"value":74023.42,"ownership":{"direct":true},"balance_after":376566,"source":{"system":"sec-edgar","filing":"0001209191-22-050315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000120919122050315/doc4.xml","form_type":"4"}},{"id":2157166,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":64914,"kind":"person","name":"MCCLUNG BARBARA G","position":1,"cik":"0001231321","reported_name":"MCCLUNG BARBARA G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-09-16T16:14:35.000Z","date":"2022-09-15","kind":"exercise","acquired":true,"shares":77,"price":2.69,"value":207.13,"ownership":{"direct":true},"balance_after":349048,"source":{"system":"sec-edgar","filing":"0001209191-22-050315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1231321/000120919122050315/doc4.xml","form_type":"4"}}],"next_cursor":"2022-09-16T16:14:35.000000Z,2157166"}